<code id='CE66226C43'></code><style id='CE66226C43'></style>
    • <acronym id='CE66226C43'></acronym>
      <center id='CE66226C43'><center id='CE66226C43'><tfoot id='CE66226C43'></tfoot></center><abbr id='CE66226C43'><dir id='CE66226C43'><tfoot id='CE66226C43'></tfoot><noframes id='CE66226C43'>

    • <optgroup id='CE66226C43'><strike id='CE66226C43'><sup id='CE66226C43'></sup></strike><code id='CE66226C43'></code></optgroup>
        1. <b id='CE66226C43'><label id='CE66226C43'><select id='CE66226C43'><dt id='CE66226C43'><span id='CE66226C43'></span></dt></select></label></b><u id='CE66226C43'></u>
          <i id='CE66226C43'><strike id='CE66226C43'><tt id='CE66226C43'><pre id='CE66226C43'></pre></tt></strike></i>

          focus

          focus

          author:comprehensive    Page View:175
          the shape of a medical note connected by dots and lines — health tech coverage from STAT
          Adobe

          In recent months, the federal government has repeatedly told Medicare Advantage insurers that they cannot use artificial intelligence or algorithms to deny medical services the government routinely covers.

          But in finalizing a rule to that effect, it also stepped into a thicket of questions from insurers about a technology that is especially difficult to pin down: What is AI? Can it be used at all to make decisions about the coverage of older patients? If so, how?

          advertisement

          This week, the federal agency that oversees Medicare sought to boil it all down into a simple directive: Put the circumstances of the individual patient first, and your algorithm second.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Anesthesiologist group: stop taking Ozempic before surgery
          Anesthesiologist group: stop taking Ozempic before surgery

          EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

          read more
          Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline
          Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

          Bayer'sU.S.president,SebastianGuth,emphasizedataninterviewattheSTATofficesinBostonthatthepharmacompa

          read more
          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more

          In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

          AlastairGrant/APLONDON— AstraZenecasaidThursdayitwouldpurchasetheFrenchfirmAmolytPharmainadealworthu